|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized, Double- Blind, Placebo -Controlled Trial of Long -Acting Release Octreotide for Treatment of Graves' Ophthalmopathy 显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinol Metab2006，91，12： | 1 |
| 2 | Pathogenesis of Graves ophthalmopathy:implications for prediction,prevention,and treatment显示文摘 | Garrity JA Bahn RS | 2006 | Am J Ophthalmol2006，142，1： | 1 |
| 3 | Inflammatory orbital pseudotumor with extension beyond the orbit 显示文摘 | Mahr MA Salomao DR Garrity JA | 2004 | Am J Ophthal- mol2004，138，39： | 1 |
| 4 | Risk factors for ischemic optic neuropathy after cardiopulmonary bypass: A matched case/control study显示文摘 | Nuttall GA Garrity JA Dearani JA | 2001 | Anesth Analg2001，93，： | 1 |
| 5 | Pathogenesis of graves ophthalmopathy:implications for prediction,prevention,and treatment显示文摘 | Garrity JA Bahn RS | | 0，，01： | 1 |
| 6 | Imaging for neuro-ophthalmic and orbital disease显示文摘 | Lee AG Brazis PW Garrity JA | 2014 | American Journal of Ophthalmology2014，1，38： | 1 |
| 7 | Randomized, double-blind, placebo -controlled trial of long-acting release octreotide for treatment of Graves' ophthalmopathy 显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinal Metab2006，91，12： | 1 |
| 8 | The evaluation and treatment of graves ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 9 | Pathogenesis of Graves ophthalmopathy:Implications for prediction,prevention and treatment显示文摘 | Garrity JA Bahn RS | 2006 | Am J Ophthalm ol2006，142，1： | 1 |
| 10 | Imaging for neuro-ophthalmic and orbital disease显示文摘 | Lee AG Brazis PW Garrity JA | | 0，，： | 1 |
| 11 | The Evaluation and Treatment of Graves Ophthalmopathy显示文摘 | Stan MN Garrity JA Bahn RS | 2012 | Med Clin North Am2012，96，2： | 1 |
| 12 | Eye Care for Patients Receiving Neuromuscular Blocking Agents or Propofol During Mechanical Ventilation显示文摘 | Garrity JA | 2000 | Am J Crit Care2000，9，3： | 1 |
| 13 | Pathogenesis of Graves ophthal- mopathy: implications for prediction, prevention, and treatment显示文摘 | Garrity JA Bahn RS | 2006 | Am J Ophthalmol2006，142，1： | 1 |
| 14 | Diagnostic evaluation of Graves' ophthalmopathy显示文摘 | Bahan RS Garrity JA Gorman CA | 1988 | Endocrinol Metab Clin North Am1988，17，： | 1 |
| 15 | Aprospective,randomized,double-blind,placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy显示文摘 | Gorman CA Garrity JA Fatourechi V | 2001 | Ophthalmology2001，108，： | 1 |
| 16 | Randomized, double-blind, placebo-controlled trial of long-acting release oetreotide for treatment of Graves' ophthalmopathy显示文摘 | Stan MN Garrity JA Bradley EA | 2006 | J Clin Endocrinol Metab2006，91，12： | 1 |
| 17 | Orbital inflammation with IgG4-positive plasma cells: manifestation of lgG4 systemic disease显示文摘 | Plaza JA Garrity JA Dogan A | 2011 | Arch Ophthalmol2011，129，4： | 1 |
| 18 | Pathogenesis of graves ophthalmopathy:im- plications for prediction,prevention,and treatment显示文摘 | Garrity JA Bahn RS | 2006 | Am J Oph- thalmol2006，142，1： | 1 |
| 19 | Imaging for neuro-ophthalmic and orbital disease显示文摘 | Lee AG Brazis PW Garrity JA | 2004 | Am J Ophthalmol2004，138，5： | 1 |
| 20 | A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy显示文摘 | Gorman CA Garrity JA Fatourechi V | 2001 | Ophthalmology2001，108，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员